Conditions: Schizophrenia
Keywords: Oxytocin
Allocation: RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 14
Healthy volunteers: no

Brief summary:
The Objective of this study is to investigate the long-term efficacy of intranasal oxytocin in improvement of symptoms in patients with schizophrenia who have residual symptoms dispute being on adequate treatment with antipsychotic medication.

Detailed description:
Approximately 20 patients will be enrolled to participate in a 6 month flexible dose of oxytocin.

Arms:
arm 1: Oxytocin twice daily for 3 weeks arm 2: Placebo for 3 weeks

Interventions: intervention 1: Oxytocin: 24IU - 168 IU intervention 2: Placebo
Intervention descriptions: intervention 1: Oxytocin: 24IU - 168 IU intervention 2: placebo drug

Protocol document: